Early administration of the GIP receptor antagonist (Pro(3))GIP counters development of hyperglycaemia, glucose intolerance and insulin resistance in genetic obesity

P.R. Flatt, N. Irwin, P.L. McClean, Brian Green, V.A. Gault, C.J. Bailey, F.P.M. O'Harte

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)
Original languageEnglish
Pages (from-to)108-109
Number of pages2
Publication statusPublished - 2006

Cite this